For Immediate Release 17 September 2019
MILLENNIUM & COPTHORNE HOTELS PLC ("THE COMPANY")
NOTIFICATION OF TRANSACTION OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY ("PDMR'S") AND PERSONS CLOSELY ASSOCIATED WITH THEM ("PCA'S")
Provided in accordance with Article 19.3 of the EU Market Abuse Regulation No. 596/2014
LEI Number: 2138003EQ1O4LZ1JNH19
Further to the announcement on 12 September 2019 that the cash offer made on 7 June 2019 by Agapier Investments Limited ("Bidco") (a company indirectly and wholly-owned by City Developments Limited ("CDL")) for
Further details of each transaction are included in the table below.
1. |
Details of the person discharging managerial responsibilities/ person closely associated |
||||||
a) |
Name |
Lawrence Yip |
|||||
2. |
Reason for the notification |
||||||
a) |
Position/status |
Senior Vice President, North Asia |
|||||
b) |
Initial notification/ Amendment |
Initial notification |
|||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||
a) |
Full Name of the Legal Enity |
Millennium & Copthorne Hotels plc |
|||||
b) |
LEI |
2138003EQ104LZ1JNH19 |
|||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted |
||||||
a) |
Description of the financial instrument, type of instrument |
Ordinary Shares of 30p each
|
|||||
b) |
Identification code |
GB0005622542 |
|||||
c) |
Nature of the transaction |
Disposal of shares to accept the Final Offer. |
|||||
d) |
Price(s) and volume(s) |
|
|||||
e) |
Aggregated information - Aggregated volume - Price |
See 4.e) above
|
|||||
f) |
Date of the transaction |
12 September 2019 |
|||||
g) |
Place of the transaction |
London Stock Exchange Main Market (XLON) |
|||||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.